BRIEF-Tonix Pharmaceuticals Announces That Its Single Dose Mpox Vaccine Candidate Tnx-801 Aligns With Who's Newly Issued Preferred Target Product Profile For Mpox Vaccines In Global Health Emergency
Sept 16 - Tonix Pharmaceuticals Holding Corp : * TONIX PHARMACEUTICALS ANNOUNCES THAT ITS SINGLE DOSE MPOX VACCINE CANDIDATE TNX-801 ALIGNS WITH WHO’S NEWLY ISSUED PREFERRED TARGET PRODUCT PROFILE FOR MPOX VACCINES IN GLOBAL HEALTH EMERGENCYSource text for Eikon: Further company coverage: